Posted by Admin
Post Date : Monday September 3 2007

CC is a 55-year old woman diagnosed with MALT lymphoma stage 1 around her stomach area in October 2003. MALT lymphoma is a relatively rare form of non-Hodgkin’s lymphoma. Prior to her diagnosis her symptoms of heartburn, difficulty swallowing and fullness were treated with Prilosec in August 2003 after receiving an ultrasound and endoscope of her stomach. She took the medication for one month and did not experience any relief. CC had a repeat endoscope accompanied by a biopsy in October after which time she was diagnosed with MALT lymphoma. Surgery was not an option for this type of cancer so instead she was treated with Rituxan. CC received the treatment via intravenous administration once per week for 6 weeks. After the treatment was completed she received another endoscope and there was no change in her condition. Despite treatment failure, CC was told to wait a few months and then to take another round of treatment. She completed the treatment in April 2004 and once again endoscopic evaluation revealed no change. However, she developed Heliobacter pylori infection and was treated with Helidac. In March 2005, CC went to the Mayo Clinic for a second opinion. A PET scan confirmed MALT lymphoma in her stomach. Fortunately, the PET scan showed the cancer confined only to her stomach area and had not spread anywhere else. The Mayo clinic only offered more chemotherapy which she refused. CC started to investigate alternative treatment on her own and found information about Poly-MVA. She started Poly-MVA on August 23, 2005. She initially received it via intravenous infusion. She received 20 cc five days in a row week 1; week 2 she received 30 cc twice per week; week 3 she received 35 cc twice per week and week 4 she received 40 cc four times in one week. CC consumed 8 teaspoons of Poly-MVA orally on non-IV days. She also received via intravenous infusion hydrogen peroxide on the days she received the Poly-MVA. Since September 2005, CC has consistently been taking 8 teaspoons per day of Poly-MVA. She had a PET scan of her abdomen on May 11, 2006 that demonstrated a significant reduction of the hypermetabolic lymphadenopathy that was seen on her previous scan. CC received an MRI on August 31, 2006 of her brain and neck. The results were normal. On September 5, 2006, CC’s beta-2-microglobulin was normal at 1.9 mg/L. She feels great and has an excellent quality of life. She does not have any symptoms of the MALT lymphoma which she had at the beginning. CC will receive a follow up scan in the next few months and the results will be reported.

Case study written by Dr. Shari Lieberman as a part of the Poly-MVA Best Case Series.